中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss

文献类型:期刊论文

作者Jiang, Min2; Wang, Tianqi2; Yan, Xueming2; Liu, Zhuochao2; Yan, Yufei2; Yang, Kai2; Qi, Jin2; Zhou, Hanbing2; Qian, Niandong2; Zhou, Qi2
刊名Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
出版日期2018-10-15
ISSN号1523-4681
DOI10.1002/jbmr.3604
文献子类Article
英文摘要Osteoporosis, an osteolytic disease that affects millions of people worldwide, features a bone remodeling imbalance between bone resorption by osteoclasts and bone formation by osteoblasts. Identifying dual target-directed agents that inhibit excessive bone resorption and increase bone formation is considered an efficient strategy for developing new osteoporosis treatments. Rhein, a natural anthraquinone, can be isolated from various Asian herbal medicines. Rhein and its derivatives have been reported to have various beneficial pharmacological effects, especially their bone-targeting ability and anti-osteoclastogenesis activity. Moreover, hydrogen sulfide (H S) was reported to prevent ovariectomy- (OVX-) induced bone loss by enhancing bone formation, and sulfur replacement therapy has been considered a novel and plausible therapeutic option. Based on this information, we synthesized a rhein-derived thioamide (RT) and investigated its effects on bone resorption and bone formation in vitro and in vivo. It has been found that the RT-inhibited receptor activator of the nuclear factor-κB (NF-κB) ligand- (RANKL-) induced osteoclastogenesis and bone resorption in a dose-dependent manner. The expression of osteoclast marker genes was also suppressed by RT treatment. Furthermore, exploration of signal transduction pathways indicated that RT markedly blocked RANKL-induced osteoclastogenesis by attenuating MAPK pathways. However, RT treatment in an osteoblastic cell line, MC3TE-E1, indicated that RT led to an increase in the deposition of minerals and the expression of osteoblast marker genes, as demonstrated by Alizarin Red staining and alkaline phosphatase activity. Importantly, an OVX mouse model showed that RT could attenuate the bone loss in estrogen deficiency-induced osteoporosis in vivo with a smart H S-releasing property and that there was a considerable improvement in the biomechanical properties of bone. Accordingly, our current work highlights the dual regulation of bone remodeling by the rhein-derived molecule RT. This may be a highly promising approach for a new type of anti-osteoporosis agent. © 2018 American Society for Bone and Mineral Research.
语种英语
源URL[http://119.78.100.183/handle/2S10ELR8/266320]  
专题新药研究国家重点实验室
作者单位1.Department of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
2.Shanghai Key Laboratory for Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China;
推荐引用方式
GB/T 7714
Jiang, Min,Wang, Tianqi,Yan, Xueming,et al. A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss[J]. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,2018.
APA Jiang, Min.,Wang, Tianqi.,Yan, Xueming.,Liu, Zhuochao.,Yan, Yufei.,...&Deng, Lianfu.(2018).A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
MLA Jiang, Min,et al."A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss".Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (2018).

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。